Anthony E. Altig, Director at OPTIMER PHARMACEUTICALS INC (OPTR), bought 5,000 shares at $7.44 ($37K) on 2011-08-09, disclosed to the SEC on 2011-08-09.
Open-market purchase of $37k OPTR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| DVSA | SELL | 2007-02-26 | $13K | — | Filing → |
| DVSA | SELL | 2007-02-20 | $72K | — | Filing → |
| DVSA | SELL | 2006-02-27 | $4K | — | Filing → |